453 related articles for article (PubMed ID: 12370347)
21. Human anergic/suppressive CD4(+)CD25(+) T cells: a highly differentiated and apoptosis-prone population.
Taams LS; Smith J; Rustin MH; Salmon M; Poulter LW; Akbar AN
Eur J Immunol; 2001 Apr; 31(4):1122-31. PubMed ID: 11298337
[TBL] [Abstract][Full Text] [Related]
22. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta.
Xu L; Kitani A; Fuss I; Strober W
J Immunol; 2007 Jun; 178(11):6725-9. PubMed ID: 17513718
[TBL] [Abstract][Full Text] [Related]
23. Transforming growth factor beta 1 costimulated growth and regulatory function of staphylococcal enterotoxin B-responsive CD8+ T cells.
Rich S; Seelig M; Lee HM; Lin J
J Immunol; 1995 Jul; 155(2):609-18. PubMed ID: 7608539
[TBL] [Abstract][Full Text] [Related]
24. Complementary role of CD4+CD25+ regulatory T cells and TGF-beta in oral tolerance.
Chung Y; Lee SH; Kim DH; Kang CY
J Leukoc Biol; 2005 Jun; 77(6):906-13. PubMed ID: 15758078
[TBL] [Abstract][Full Text] [Related]
25. Role for thymic and splenic regulatory CD4+ T cells induced by donor dendritic cells in allograft tolerance by LF15-0195 treatment.
Chiffoleau E; Bériou G; Dutartre P; Usal C; Soulillou JP; Cuturi MC
J Immunol; 2002 May; 168(10):5058-69. PubMed ID: 11994458
[TBL] [Abstract][Full Text] [Related]
26. CD4(+)CD25(+) regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness.
Piccirillo CA; Letterio JJ; Thornton AM; McHugh RS; Mamura M; Mizuhara H; Shevach EM
J Exp Med; 2002 Jul; 196(2):237-46. PubMed ID: 12119348
[TBL] [Abstract][Full Text] [Related]
27. The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases.
Horwitz DA; Gray JD; Zheng SG
Arthritis Res; 2002; 4(4):241-6. PubMed ID: 12106494
[TBL] [Abstract][Full Text] [Related]
28. CD4+ CD25+ transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response.
Mason CM; Porretta E; Zhang P; Nelson S
Clin Exp Immunol; 2007 Jun; 148(3):537-45. PubMed ID: 17362490
[TBL] [Abstract][Full Text] [Related]
29. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
30. Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.
Karim M; Kingsley CI; Bushell AR; Sawitzki BS; Wood KJ
J Immunol; 2004 Jan; 172(2):923-8. PubMed ID: 14707064
[TBL] [Abstract][Full Text] [Related]
31. Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes.
Cosmi L; Liotta F; Lazzeri E; Francalanci M; Angeli R; Mazzinghi B; Santarlasci V; Manetti R; Vanini V; Romagnani P; Maggi E; Romagnani S; Annunziato F
Blood; 2003 Dec; 102(12):4107-14. PubMed ID: 12893750
[TBL] [Abstract][Full Text] [Related]
32. Human CD19(+)CD25(high) B regulatory cells suppress proliferation of CD4(+) T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells.
Kessel A; Haj T; Peri R; Snir A; Melamed D; Sabo E; Toubi E
Autoimmun Rev; 2012 Jul; 11(9):670-7. PubMed ID: 22155204
[TBL] [Abstract][Full Text] [Related]
33. Human CD25+ regulatory T cells maintain immune tolerance to nickel in healthy, nonallergic individuals.
Cavani A; Nasorri F; Ottaviani C; Sebastiani S; De Pità O; Girolomoni G
J Immunol; 2003 Dec; 171(11):5760-8. PubMed ID: 14634084
[TBL] [Abstract][Full Text] [Related]
34. CD4+CD25+ regulatory T cells cure murine colitis: the role of IL-10, TGF-beta, and CTLA4.
Liu H; Hu B; Xu D; Liew FY
J Immunol; 2003 Nov; 171(10):5012-7. PubMed ID: 14607897
[TBL] [Abstract][Full Text] [Related]
35. Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3.
Chen W; Jin W; Hardegen N; Lei KJ; Li L; Marinos N; McGrady G; Wahl SM
J Exp Med; 2003 Dec; 198(12):1875-86. PubMed ID: 14676299
[TBL] [Abstract][Full Text] [Related]
36. CD4(+) CD25(low) GITR(+) cells: a novel human CD4(+) T-cell population with regulatory activity.
Bianchini R; Bistoni O; Alunno A; Petrillo MG; Ronchetti S; Sportoletti P; Bocci EB; Nocentini G; Gerli R; Riccardi C
Eur J Immunol; 2011 Aug; 41(8):2269-78. PubMed ID: 21557210
[TBL] [Abstract][Full Text] [Related]
37. Control of T-cell activation by CD4+ CD25+ suppressor T cells.
Shevach EM; McHugh RS; Piccirillo CA; Thornton AM
Immunol Rev; 2001 Aug; 182():58-67. PubMed ID: 11722623
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development.
Gregori S; Giarratana N; Smiroldo S; Adorini L
J Immunol; 2003 Oct; 171(8):4040-7. PubMed ID: 14530324
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells.
Banz A; Pontoux C; Papiernik M
J Immunol; 2002 Jul; 169(2):750-7. PubMed ID: 12097377
[TBL] [Abstract][Full Text] [Related]
40. The IL-4 receptor alpha-chain-binding cytokines, IL-4 and IL-13, induce forkhead box P3-expressing CD25+CD4+ regulatory T cells from CD25-CD4+ precursors.
Skapenko A; Kalden JR; Lipsky PE; Schulze-Koops H
J Immunol; 2005 Nov; 175(9):6107-16. PubMed ID: 16237107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
